Australian Melanoma Research Foundation

Trialbee's Jamie Goldfarb Earns Linnea Olson Award for Lifelong Advocacy Connecting Patients With Clinical Research

Retrieved on: 
Mittwoch, November 8, 2023
Neoplasm, Imerman Angels, Medidata Solutions, Regenerative medicine, National Institutes of Health, Sheraton New York Times Square Hotel, NCI, ARM, Goldfarb, Life, Hope, Congress, Pancreas, Face, Liver, Patient, Research, TIL, Australian Melanoma Research Foundation, Friends, MRF, Euronext Paris, Disease, Clinical trial, Ecosystem, National Cancer Institute, NIH, Melanoma, Family, Cancer, MRA, Dassault Group, Bangladesh Technical Education Board, Nursing, Bank, Pharmaceutical industry, Medical imaging

CHAPEL HILL, N.C. and MALMO, Sweden, Nov. 8, 2023 /PRNewswire-PRWeb/ -- Trialbee, the global team revolutionizing the patient recruitment ecosystem with technology, people, and passion, today announced Jamie Goldfarb, its Director of Patient Recruitment Strategy, was named the recipient of the 2023 Linnea Olson Award for lifelong achievements in patient advocacy.

Key Points: 
  • Goldfarb was diagnosed with melanoma for a third time in January 2011 — 11 weeks after giving birth to her son, Kai.
  • Throughout her experience, Goldfarb realized not all patients are aware of clinical research opportunities that may be available to them, especially in oncology.
  • I do it because a clinical trial saved my life, yet less than 5% of patients with cancer ever participate in clinical research.
  • Goldfarb accepted the Linnea Olson Award at the Medidata NEXT New York conference at the Sheraton New York Times Square Hotel on November 7.

The Melanoma Research Foundation Launches the Legacy of Progress Endowment Fund

Retrieved on: 
Mittwoch, November 1, 2023
Survival, Legacy, Australian Melanoma Research Foundation, Research, Progress, MRF, Financial endowment, Melanoma, Cancer, Immunotherapy, United States-India Science & Technology Endowment Fund, Pharmaceutical industry

WASHINGTON, Nov. 1, 2023 /PRNewswire-PRWeb/ -- Endowment Poised to Advance Critical Melanoma Research

Key Points: 
  • The transformative and pioneering endowment initiative highlights the Foundation's unwavering goal to advance melanoma research, treatment and patient support and denotes a commitment to creating a lasting impact for the melanoma community.
  • The Melanoma Research Foundation (MRF) is the largest independent melanoma patient advocacy organization dedicated to advancing medical research towards new treatments and ultimately, a cure.
  • Today, the MRF proudly announces the launch of its Legacy of Progress Endowment Fund.
  • "Research advancement proved to be the answer for me as I battled melanoma which is why I know the Legacy of Progress Endowment Fund will enable on-going support for research needed to eliminate melanoma."

The Melanoma Research Foundation to Host the 2023 LA Miles for Melanoma 5K!

Retrieved on: 
Donnerstag, September 21, 2023
Jonsson Comprehensive Cancer Center, Survivor, University, MRF, Dermatology, Australian Melanoma Research Foundation, Research, USC, Mile, Griffith Park, Novartis, Patient, Los, LOS, K, Vaccine, Nightclub, Pharmaceutical industry, L.A, Melanoma

LOS ANGELES, Sept. 21, 2023 /PRNewswire-PRWeb/ -- The Melanoma Research Foundation (MRF) is thrilled to announce the next event in its annual Miles for Melanoma nationwide 5K program, bringing together local melanoma patients, care partners and survivors. This year we will be hosting our annual L.A. event on Saturday, October 7, 2023, at Griffith Park at 7:30am PT. The 5k walk/race will bring together the Los Angeles-area melanoma community with a goal of raising $70,000 in support of critical melanoma research.

Key Points: 
  • The Melanoma Research Foundation (MRF) is thrilled to announce the next event in its annual Miles for Melanoma nationwide 5K program, bringing together local melanoma patients, care partners and survivors.
  • The 5k walk/race will bring together the Los Angeles-area melanoma community with a goal of raising $70,000 in support of critical melanoma research.
  • LOS ANGELES, Sept. 21, 2023 /PRNewswire-PRWeb/ -- The Melanoma Research Foundation (MRF) is thrilled to announce the next event in its annual Miles for Melanoma nationwide 5K program, bringing together local melanoma patients, care partners and survivors.
  • Miles for Melanoma 5K event here by Wednesday, October 4th, 2023, at 11:59PM PT.

Andy Cohen Poised to Help the Melanoma Research Foundation Raise Over $1 Million for the Melanoma Community as the New York City Gala Emcee

Retrieved on: 
Mittwoch, August 2, 2023
Charlie Conacher Humanitarian Award, MRF, Australian Melanoma Research Foundation, Hope, Research, FAAD, Ed Block Courage Award, Patient, Melanoma, FACS, Personality, Plaza Hotel, Pod, Caregiver, Pharmaceutical industry, The New York Times, MD

New York, August 2, 2023 /PRNewswire-PRWeb/ -- The Melanoma Research Foundation (MRF) will host its 22nd annual New York City Gala on Thursday, October 26 at The Plaza Hotel. This year's event will recognize the tremendous scientific and treatment advancements that have benefited the melanoma community, honor melanoma patients, thrivers, caregivers and clinicians and raise critical funds enabling the MRF to extend its critical mission. The gala welcomes Emmy award-winning host, producer, New York Times best-selling author, melanoma survivor and advocate, Andy Cohen, as headliner for the third consecutive year.

Key Points: 
  • New York, August 2, 2023 /PRNewswire-PRWeb/ -- The Melanoma Research Foundation (MRF) will host its 22nd annual New York City Gala on Thursday, October 26 at The Plaza Hotel.
  • The gala welcomes Emmy award-winning host, producer, New York Times best-selling author, melanoma survivor and advocate, Andy Cohen, as headliner for the third consecutive year.
  • "It is an honor to be a part of an unforgettable evening celebrating melanoma patients, caregivers and clinicians while honoring the tremendous achievements made across the melanoma community," said Andy Cohen.
  • "As a melanoma survivor, I am aware of the critical need to support continued research to foster effective clinical trials and treatments that will one day help eradicate melanoma!"

City of Hope scientists develop targeted chemotherapy able to kill all solid tumors in preclinical research

Retrieved on: 
Dienstag, August 1, 2023
Linda, Molecule, Alex's Lemonade Stand Foundation, DNA, Rituximab, Insulin, Human, City of Hope National Medical Center, City of Hope, R01, Neoplasm, Biotechnology, Cell Chemical Biology, Trastuzumab, Clinical trial, Ovary, Breast, Toxicity, Brain, Research, Gene expression, Prostate, Treatment of lung cancer, Cell, Molecular diagnostics, Translational Genomics Research Institute, Cetuximab, Experiment, RLL, Bangladesh Technical Education Board, DNA replication, National Cancer Institute, S phase, Australian Melanoma Research Foundation, Patient, Department of Defense Serum Repository, Apoptosis, LOS, Beckman Research Institute, Proliferating cell nuclear antigen, Therapy, Skin, PCNA, Vaccine, Pharmaceutical industry, Molecular oncology, City, Hope

LOS ANGELES, Aug. 1, 2023 /PRNewswire/ -- Researchers at City of Hope, one of the largest cancer research and treatment organizations in the United States, today published a new study explaining how they took a protein once thought to be too challenging for targeted therapy, proliferating cell nuclear antigen (PCNA), and developed a targeted chemotherapy that appears to annihilate all solid tumors in preclinical research. As the scientists continue to investigate the foundational mechanisms that make this cancer-stopping pill work in animal models, they note that there is an ongoing Phase 1 clinical trial testing the City of Hope-developed therapeutic in humans.

Key Points: 
  • Data suggests PCNA is uniquely altered in cancer cells, and this fact allowed us to design a drug that targeted only the form of PCNA in cancer cells.
  • The investigational chemotherapeutic is currently in a Phase 1 clinical trial in humans at City of Hope."
  • Now that we know the problem area and can inhibit it, we will dig deeper to understand the process to develop more personalized, targeted cancer medicines."
  • "City of Hope has world leaders in cancer research.

Majic WMJI Morning Show Host Mark Nolan to Emcee Melanoma Research Foundation's Miles for Melanoma 5K

Retrieved on: 
Donnerstag, Juli 20, 2023
Survivor, Cleveland Clinic, Neutrogena, MetroHealth, WMJI, Beauty, Atmosphere, Golden Joystick Awards, MRF, Edgewater Park, WOIO, Australian Melanoma Research Foundation, Bristol Myers Squibb, Research, Mile, WGAR, Kent State University, Novartis, Patient, OHG, Weather, 2000 Summer Olympics opening ceremony, Everything's Beautiful, News, Majical Cloudz, Caregiver, Disease, Adolescence, Television, Vaccine, Parker, Dermatology, Melanoma

CLEVELAND, July 20, 2023 /PRNewswire-PRWeb/ -- The Melanoma Research Foundation (MRF) is thrilled to announce that Mark Nolan, broadcaster of the Majic WMJI 105.7, Cleveland's greatest hits station, will be returning as the event emcee for the annual Cleveland Miles for Melanoma 5k program on Sunday, August 6, 2023, at Edgewater Park. Nolan will welcome guests to the Opening Ceremonies beginning at 8:30AM ET and kick off the 5K which starts at 9:00AM ET.

Key Points: 
  • CLEVELAND, July 20, 2023 /PRNewswire-PRWeb/ -- The Melanoma Research Foundation (MRF) is thrilled to announce that Mark Nolan, broadcaster of the Majic WMJI 105.7, Cleveland's greatest hits station, will be returning as the event emcee for the annual Cleveland Miles for Melanoma 5k program on Sunday, August 6, 2023, at Edgewater Park.
  • Nolan will welcome guests to the Opening Ceremonies beginning at 8:30AM ET and kick off the 5K which starts at 9:00AM ET.
  • The 5k walk/race will bring together the Cleveland-area melanoma community with a goal of raising $115,000 in support of critical melanoma research.
  • Register to attend the Cleveland Miles for Melanoma 5K event here by Thursday, August 3, 2023, at 11:59PM ET.

WCVB Channel 5 Chronicle Reporter and Producer Nicole Estaphan to Emcee Melanoma Research Foundation's Miles for Melanoma 5K

Retrieved on: 
Mittwoch, Mai 3, 2023
Volunteering, Survivor, WAGA-TV, Poverty, Muscular dystrophy, Golden Joystick Awards, MRF, National Brain Tumor Society, Franklin Park Zoo, Australian Melanoma Research Foundation, Human, Research, Mile, Leukemia & Lymphoma Society, Franklin, Patient, Muscular Dystrophy Association, 2000 Summer Olympics opening ceremony, Massachusetts General Hospital, Therapy, Leukemia, WCVB, Vaccine, Pharmaceutical industry, Melanoma

BOSTON, May 3, 2023 /PRNewswire-PRWeb/ -- The Melanoma Research Foundation (MRF) is thrilled to announce that WCVB Channel 5 Chronicle Reporter and Producer Nicole Estaphan will be returning as the event emcee for the annual Miles for Melanoma New England 5K event on Saturday, May 13, 2023, at the Franklin Park Zoo. Estaphan will welcome guests to the Opening Ceremonies beginning at 8:30AM ET and kick off the 5K which starts at 9:00AM ET. This event will bring together hundreds of New England melanoma patients, survivors and their families with a goal of raising $70,000 for melanoma research.

Key Points: 
  • BOSTON, May 3, 2023 /PRNewswire-PRWeb/ -- The Melanoma Research Foundation (MRF) is thrilled to announce that WCVB Channel 5 Chronicle Reporter and Producer Nicole Estaphan will be returning as the event emcee for the annual Miles for Melanoma New England 5K event on Saturday, May 13, 2023, at the Franklin Park Zoo.
  • Estaphan will welcome guests to the Opening Ceremonies beginning at 8:30AM ET and kick off the 5K which starts at 9:00AM ET.
  • This event will bring together hundreds of New England melanoma patients, survivors and their families with a goal of raising $70,000 for melanoma research.
  • In addition to being the Miles for Melanoma New England emcee, Estaphan joined WCVB NewsCenter 5 in January of 2016 as a freelance news reporter.

Teddi Mellencamp Gets Naked for Melanoma Awareness Month

Retrieved on: 
Montag, Mai 1, 2023
Neutrogena, MRF, Acral lentiginous melanoma, Skin cancer, Australian Melanoma Research Foundation, Bristol Myers Squibb, Research, Social media, Mile, Melanoma, Eisai, Patient, Personality, Skin, Pharmaceutical industry

WASHINGTON, May 1, 2023 /PRNewswire-PRWeb/ -- The Melanoma Research Foundation (MRF) is pleased to announce the launch of its annual award-winning #GetNaked campaign in recognition of Melanoma Awareness Month this May. TV personality, wellness coach, host of the top-rated podcast "Two Ts in a Pod," melanoma survivor and advocate Teddi Mellencamp will serve as this year's #GetNaked campaign spokesperson. In this role, Teddi will join the MRF's #GetNaked campaign focused on generating awareness around early-detection and educating the public about melanoma prevention.

Key Points: 
  • WASHINGTON, May 1, 2023 /PRNewswire-PRWeb/ -- The Melanoma Research Foundation (MRF) is pleased to announce the launch of its annual award-winning #GetNaked campaign in recognition of Melanoma Awareness Month this May.
  • In this role, Teddi will join the MRF's #GetNaked campaign focused on generating awareness around early-detection and educating the public about melanoma prevention.
  • "Teddi Mellencamp is an incredible melanoma advocate dedicated to raising awareness and encouraging early detection of this preventable disease," says MRF CEO Kyleigh LiPira.
  • The MRF would like to thank its Melanoma Awareness Month corporate sponsors, Bristol Myers Squibb , Neutrogena , Cabana Life and Eisai for their generous support.

Patient-Led Organizations Join Forces With Komodo Health To Drive Access to High-Quality Care Using Real-World Evidence

Retrieved on: 
Dienstag, Februar 14, 2023
Venture Capital, Clinical Trials, Professional Services, Biotechnology, Other Health, Health, Pharmaceutical, General Health, Oncology, Komodo, Organization, The One Network, Australian Melanoma Research Foundation, Bone marrow, Multiple Myeloma Research Foundation, Chan Zuckerberg Initiative, Asthma and Allergy Foundation of America, Sarcoidosis, Diagnosis, FSR, Melanoma, Pancreatic serous cystadenoma, Patient, HIV disease progression rates, Entrepreneurship, Clinical trial, Pregnancy, Research, Black, Dermatology, Inflammation, Disease, Partnership, Education, Multiple myeloma, CRC, Asthma, Quality of life, Pharmaceutical industry, Nursing

These partnerships empower advocacy organizations to harness data-driven strategies to support patients and reduce disease burden at scale.

Key Points: 
  • These partnerships empower advocacy organizations to harness data-driven strategies to support patients and reduce disease burden at scale.
  • The Komodo Health platform and application suite are used by patient advocacy groups to put patient needs at the center of strategic decision-making by surfacing concrete, comprehensive insights into the care experiences of specific patient populations.
  • Komodo’s insights equip these organizations with real-world data to power their programs in ways that were previously out of reach.
  • “Patient advocacy groups play a critical, on-the-ground role in communities across the country to drive education and awareness, fund critical research, and improve standards of care for their patients,” said Web Sun, President and Co-Founder, Komodo Health.

The Melanoma Research Foundation Celebrates Giving Tuesday with Neutrogena®, Joining the Global Generosity Movement on November 29th

Retrieved on: 
Dienstag, November 29, 2022
Diagnosis, Social media, Physician, Melanoma, Caregiver, Patient, Australian Melanoma Research Foundation, Marketing, Disease, MRF, Research, Pharmaceutical industry, Neutrogena

WASHINGTON, Nov. 29, 2022 /PRNewswire-PRWeb/ -- The Melanoma Research Foundation (MRF) and Neutrogena will partner together this Giving Tuesday, November 29th, to raise over $100,000 for critical melanoma research to benefit patients and caregivers and raise awareness about the importance of prevention and early detection. To assist with reaching, and potentially surpassing, the fundraising goal, Neutrogena, the MRF's National Prevention Partner, will generously match the first $20,000 donations made on Giving Tuesday.

Key Points: 
  • WASHINGTON, Nov.29, 2022 /PRNewswire-PRWeb/ -- The Melanoma Research Foundation (MRF) and Neutrogena will partner together this Giving Tuesday, November 29th, to raise over $100,000 for critical melanoma research to benefit patients and caregivers and raise awareness about the importance of prevention and early detection.
  • Giving Tuesday was launched in 2012 as a simple idea: to create a day that encourages people to do good.
  • The Melanoma Research Foundation (MRF) is the largest independent organization devoted to melanoma.
  • James Merrick, Chief Communications and Marketing Officer, Melanoma Research Foundation, 1 202-899-2622, [email protected]